The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...

Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet RAHWAY, N.J., ...

Investing.com -- BT Brands Inc (NASDAQ:BTBD) stock surged 117% in premarket trading Wednesday after the company announced a definitive merger agreement with drone solutions provider Aero Velocity Inc.

"Kiwis are naturally very humble. We have to be comfortable about wanting to win," says Jade Software chief executive Justin Mercer. “I want to double the size of the Jade community, really ...

About The Study: In patients with cardiometabolic heart failure with preserved ejection fraction, semaglutide and tirzepatide showed more than 40% risk reduction for the composite of hospitalization ...

Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet Merck (NYSE: MRK) ...

Combined company to focus on advanced drone technologies that improve efficiency and sustainability for its customer base of government and commercial clients Aero Velocity provides comprehensive ...

Major League Baseball superstar Ohtani Shohei has racked up his 100th home run for the Los Angeles Dodgers. The milestone blast was his 46th of the season and recorded his fastest exit-velocity in his ...

Tomorrow sees the launch of the new Batman #1 by Matt Fraction, Jorge Jimenez and Tomeu Moray. You know, of your comic store didn't break street date that is. Most of them didn't. But with Fraction ...

Shoppers unable to afford the famous Chanel tweed jacket can get this look-alike for a 'fraction of the cost'. Next is selling the Black Boucle Textured Longline Jacket for £62 that is still available ...

Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...